SCHEMBL4895869

SCHEMBL4895869

COC(=O)c1cc(S(=O)(=O)NCCc2ccc(NS(=O)(=O)c3ccc(C(F)(F)F)cc3)cc2)ccc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.49
MEN1 O00255 1/20 0.49
ALOX15 P16050 1/20 0.49
KMT2A Q03164 1/20 0.49
BRD4 O60885 1/20 0.48
POLB P06746 2/20 0.47
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
TP53 P04637 1/20 0.46
RECQL P46063 1/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906829 0.91 ALDH1A1 (0.51) MEN1KMT2APOLBLMNAMAPT
SCHEMBL4904049 0.91 POLB (0.53) MAPK1MEN1ALOX15KMT2ABRD4
SCHEMBL4894513 0.90 HTT (0.48) MAPK1MEN1KMT2ALMNAMAPT
SCHEMBL4905405 0.89 POLB (0.58) MEN1KMT2APOLBLMNAMAPT
SCHEMBL4905912 0.89 MAPT (0.54) MEN1KMT2APOLBLMNAMAPT
SCHEMBL4906499 0.88 ALDH1A1 (0.48) MAPK1MEN1KMT2APOLBLMNA
SCHEMBL4899749 0.86 ERBB2 (0.50) MAPK1MAPTPKMHTTSMN1; SMN2
SCHEMBL5371871 0.86 MEN1 (0.57) MAPK1MEN1ALOX15KMT2ABRD4
SCHEMBL5368417 0.84 ALOX15 (0.48) MAPK1MEN1ALOX15KMT2ABRD4
SCHEMBL4902854 0.83 RECQL (0.56) MEN1KMT2APOLBLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MAPK1 3332/4885MEN1 4859/4885ALOX15 1473/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MAPK1 3366/4885MEN1 4855/4885ALOX15 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.